White Coat Hypertension
8
1
1
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
13%
1 trials in Phase 3/4
20%
1 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (8)
Virtual Reality as a Tool to Lower Blood Pressure and Anxiety in Clinic Settings
Cardiovascular Risk in Children With Chronic Conditions Study
Implementing Hypertension Screening Guidelines in Primary Care
White-coat Hypertension in Childhood - Effects on Blood Pressure and Organ Damage
Short Term Reproducibility of Office White-coat Effect
Blood Pressure Control in ESH Excellence Centres
Renal Response to Lower Body Negative Pressure in Pre-hypertensive States
Heart Rate Variability in White Coat Hypertension and Essential Hypertension